focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbingdon Healt. Share News (ABDX)

Share Price Information for Abingdon Healt. (ABDX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.00
Bid: 10.50
Ask: 11.50
Change: 0.25 (2.33%)
Spread: 1.00 (9.524%)
Open: 10.75
High: 11.00
Low: 10.75
Prev. Close: 10.75
ABDX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Abingdon Health Shares Slip On Media Speculation Around Covid Tests

Mon, 08th Feb 2021 11:20

(Alliance News) - Abingdon Health PLC shares sunk Monday after the rapid test developer and manufacturer noted a story in the Daily Mail newspaper that outlined the company's contract with the UK government has been cancelled.

Shares in Abingdon were down 13% in London on Monday mid-morning at 91.88 pence each.

https://www.dailymail.co.uk/news/article-9229507/Taxpayers-foot-87m-bill-ministers-failing-company-Covid-contract-cancel-it.html

The story, Abingdon said, covers recent announcements made by the firm.

On January 26, Abingdon - following delivery of one million virus AbC-19 virus tests for UK Department of Health & Social Care - said no further orders were expected to be placed as part of the DHSC contract. At the time, it noted the contract expired on February 14. Any future orders, Abingdon said, will be via application to future DHSC tenders, but it continues to liaise with the Medicines & Healthcare products Regulatory Agency regarding the use of its test.

The Daily Mail story, published on Saturday, said Health Secretary Matt Hancock had cancelled all further orders "with immediate effect".

The article noted Public Health England requires at least 98% accuracy for antibody tests and its evaluation was that Abingdon's offered less than 85%.

"Twice, the documents reveal, the government was warned by its own lawyers that the deals it signed with Abingdon Health - GBP2.5million for development, GBP10million for components and up to GBP75million for supply - were at 'high risk' of being ruled unlawful if challenged. The advice appears to have been ignored," the Daily Mail said.

In a statement Monday, Abingdon said: "It notes the article published in the Daily Mail on February 6, 2021 and refers investors to the RNS announcements made on December 29, 2020, January 26, 2021 and January 27, 2021 which accurately reflect the company's position and current performance."

At the end of December, Abingdon said it was working with the Medicines & Healthcare Products Regulatory Agency to secure approval for the home use and self-test of its AbC-19 Covid test. But also noted the UK Department of Health & Social Care had the option to cancel its supply of goods contract if a CE mark had not been granted for home use by December 25, but said it was continuing to "work constructively" to enable authorisation.

Abingdon has also previously noted it expects revenue of about GBP7.7 million for its half-year ended December 31, up from GBP1.5 million the year before. Second quarter revenue is "significantly ahead of the first quarter" in terms of revenue, it said. It also previously said it continues to manufacture its AbC-19 Rapid Test in anticipation of further orders and its regulatory department is working toward regulatory approval in 27 territories.

Abingdon Health PLC only listed in London in December, raising GBP22 million. It issued 22.9 million shares at 96.00p, giving the company a GBP92 million market capitalisation on admission.

At the time, Chief Executive Officer Chris Yates said: "The money raised will, amongst other things, enable us to scale up our manufacturing in order to meet the demand for our AbC-19TM rapid lateral-flow test and allow us to further establish our global commercial and operational footprint."

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
15 May 2024 14:29

Abingdon pregnancy self-tests now available under the Boots brand

(Alliance News) - Abingdon Health PLC on Wednesday said its saliva pregnancy self test is now available across the UK and online.

Read more
15 May 2024 13:00

Abingdon Health launching saliva pregnancy test with Boots

(Sharecast News) - Lateral flow contract development and manufacturing organisation Abingdon Health announced the launch of Boots' own-brand saliva pregnancy self-test across the UK and online on Wednesday, in collaboration with Salignostics and Crest Medical.

Read more
7 May 2024 20:22

TRADING UPDATES: Abingdon Health buys IVDeology Holdings

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
7 May 2024 13:20

Abingdon Health acquires IVDeology in £0.7m deal

(Sharecast News) - Lateral flow contract research, development and manufacturing provider Abingdon Health announced the acquisition of IVDeology and its subsidiaries on Tuesday, for up to £0.7m.

Read more
25 Mar 2024 15:27

Abingdon Health progresses at-home STD test programme

(Sharecast News) - Abingdon Health updated the market on the development of self-tests for sexually transmitted diseases (STDs) on Monday, announcing the completion of the 'design freeze' stage for four key tests in collaboration with Devyn.

Read more
25 Mar 2024 13:51

TRADING UPDATES: Peel Hunt's RetailBook raises GBP2.5 million

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
20 Mar 2024 11:00

Abingdon Health to launch two Boots-branded self-tests

(Sharecast News) - Lateral flow test specialist Abingdon Health announced a partnership with Crest Medical on Wednesday, to introduce Boots' own-brand rapid self-tests across the UK and online.

Read more
20 Mar 2024 10:26

Abingdon Health strikes deal amidst upswing in self testing market

(Alliance News) - Abingdon Health PLC announced on Wednesday that it will provide Boots UK Ltd with rapid lateral flow self-tests to be sold under the Boots own brand label.

Read more
20 Mar 2024 09:55

AIM WINNERS & LOSERS: Abingdon Health rises on Boots agreement

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
14 Mar 2024 15:17

EARNINGS AND TRADING: Smarttech247 and Beeks in deal boosts

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
14 Mar 2024 11:20

AIM WINNERS & LOSERS: Smartspace backs Sign In bid; Abingdon jumps

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
14 Mar 2024 09:03

LONDON MARKET OPEN: London stocks tread water with US data to come

(Alliance News) - Stocks in London barely budged after the opening bell on Thursday, after a largely softer session in New York overnight, as eyes turn to a batch of US data and what it can mean for Federal Reserve interest rates.

Read more
11 Jan 2024 12:06

Abingdon Health shares down despite decent interim results

(Alliance News) - Abingdon Health PLC on Thursday said that it remains confident in its near-term prospects, and will focus on revenue growth and cost-cutting as it looks to swing to profit.

Read more
15 Dec 2023 11:18

Abingdon Health upbeat on strong recent progress

(Sharecast News) - Lateral flow contract research, development and manufacturing organisation Abingdon Health reported solid progress on Friday as it held its annual general meeting.

Read more
15 Dec 2023 10:37

IN BRIEF: Abingdon expects higher half-year revenue

Abingdon Health PLC - York, England-based lateral flow test contract development and manufacturing company - Ahead of its annual general meeting on Friday morning, says revenue for the six months to December 31 will be "significantly higher" than GBP1.1 million a year ago. Adds that it remains "hugely focused" on continuing to grow revenue and reduce its cash-burn throughout the year ending June 30.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.